Denosumab-Related Osteonecrosis of the Jaw May Not Be a Subject of Teriparatide Treatment
- PMID: 35751544
- DOI: 10.1002/jbmr.4625
Denosumab-Related Osteonecrosis of the Jaw May Not Be a Subject of Teriparatide Treatment
Comment in
-
Reply to Potential Issues With the Use of Teriparatide After Denosumab-Related Osteonecrosis of the Jaw.J Bone Miner Res. 2022 Oct;37(10):2046-2047. doi: 10.1002/jbmr.4656. Epub 2022 Aug 4. J Bone Miner Res. 2022. PMID: 35924400 No abstract available.
Comment on
-
Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis.J Bone Miner Res. 2022 Feb;37(2):340-348. doi: 10.1002/jbmr.4472. Epub 2021 Nov 30. J Bone Miner Res. 2022. PMID: 34787342
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

